Injections Recalled for Improper Storage

McKesson Medical-Surgical Inc. is recalling a trio of injections it distributed in New Mexico, Arizona, and Utah because the products were not stored according to drug label specifications, according to the March 20, 2024, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects the following products:

• 70 vials of rocuronium bromide injection, preservative free, 10 mg/mL, 10-mL multiple-dose vials (NDC 55150-226-10), manufactured by Auromedics Pharma, McKesson product 1064081;
• 70 vials of Infuvite Adult multiple vitamins injection, 5-mL single-dose vials (NDC 54643-5649-01), manufactured by Baxter Healthcare Corp., McKesson product 519644; and 
• 70 vials of Bicillin L-A (penicillin G benzathine) 1.2 MMU/2 mL injection, 2-mL prefilled syringe (NDC 60793-0701-10), manufactured by Pfizer Pharmaceuticals, McKesson product 567951.

McKesson voluntarily initiated the recalls on February 7, 2024. The FDA designated them Class II on March 8, 2024, signaling use of the injections could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.

Rocuronium bromide injection is a prescription drug used with general anesthesia to facilitate rapid sequence and routine tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Infuvite Adult is a prescription vitamin combination used to prevent vitamin deficiency in patients 11 years and older receiving parenteral nutrition. Bicillin L-A is a prescription antibiotic injection used to treat numerous bacterial infections.